AU2002310654A1 - Bursal disease virus-like particles - Google Patents

Bursal disease virus-like particles

Info

Publication number
AU2002310654A1
AU2002310654A1 AU2002310654A AU2002310654A AU2002310654A1 AU 2002310654 A1 AU2002310654 A1 AU 2002310654A1 AU 2002310654 A AU2002310654 A AU 2002310654A AU 2002310654 A AU2002310654 A AU 2002310654A AU 2002310654 A1 AU2002310654 A1 AU 2002310654A1
Authority
AU
Australia
Prior art keywords
particles
disease virus
bursal disease
bursal
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002310654A
Inventor
Christophe Chevalier
Bernard Delmas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Publication of AU2002310654A1 publication Critical patent/AU2002310654A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2720/10045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002310654A 2001-05-02 2002-04-29 Bursal disease virus-like particles Abandoned AU2002310654A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/05858 2001-05-02
FR0105858A FR2824327B1 (en) 2001-05-02 2001-05-02 PSEUDOVIRAL PARTICLES OF BIRNAVIRUS
PCT/FR2002/001482 WO2002088339A2 (en) 2001-05-02 2002-04-29 Bursal disease virus-like particles

Publications (1)

Publication Number Publication Date
AU2002310654A1 true AU2002310654A1 (en) 2002-11-11

Family

ID=8862894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002310654A Abandoned AU2002310654A1 (en) 2001-05-02 2002-04-29 Bursal disease virus-like particles

Country Status (3)

Country Link
AU (1) AU2002310654A1 (en)
FR (1) FR2824327B1 (en)
WO (1) WO2002088339A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2217967B1 (en) * 2003-03-31 2006-01-01 Consejo Sup. Investig. Cientificas PROCEDURE FOR THE PRODUCTION OF EMPTY VIRAL PARTICLES (VLPS) OF THE INFECTIOUS BURSITIS INDUCTOR VIRUS (IBDV), COMPOSITIONS NEEDED FOR ITS POSITIONING AND ITS USE IN THE DEVELOPMENT OF VACCINES AGAINST IBDV.
ES2307345B1 (en) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas CHEMICAL EMPTY CAPSIDES OF THE VIRUS CAUSING THE INFECTIOUS BURSITIS DISEASE (IBDV), ITS PROCEDURE FOR OBTAINING AND APPLICATIONS.
ES2307346B1 (en) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas EMPTY CAPSIDES (VLPS (-VP4)) OF THE VIRUS CAUSING THE INFECTIOUS BURSITIS DISEASE (IBDV), ITS PROCESSING PROCEDURE AND APPLICATIONS.
ES2310062B1 (en) * 2005-07-15 2009-11-13 Bionostra, S.L. PSEUDOVIRAL PARTICLES CHEMICAL EMPTY DERIVED FROM VIRUS CAUSING INFECTIOUS BURSITIS DISEASE (IBDV), PROCEDURE OF OBTAINING AND APPLICATIONS.
EP2093281A1 (en) * 2008-02-19 2009-08-26 Kapsid Link, S.L. Protein nanocarriers, process for obtaining them and applications
ES2659586T3 (en) * 2008-05-09 2018-03-16 Chimera Pharma S.L.U. Chimeric fusion proteins and particles similar to Birnavirus VP2 virus
WO2011054995A2 (en) * 2009-11-06 2011-05-12 Chimera Pharma, S. L. U. PROPHYLACTIC FLU VACCINES FROM VIRAL CAPSIDS OF BIRNAVIRUS CONTAINING THE M2e ANTIGEN OF THE FLU VIRUS
CN102145166B (en) * 2011-04-21 2013-05-22 江苏省农业科学院 Infectious bursal disease VP2 subunit vaccine of recombinant avian influenza M2e, construction method of vaccine and use of vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650319T2 (en) * 1985-05-30 1996-01-25 Commw Scient Ind Res Org CLONING AND EXPRESSION OF ECONOMICAL IMMUNOGENS OF INFECTIOUS BURSAVIRUS (IBDV).
WO1989001040A1 (en) * 1987-07-27 1989-02-09 Syntro Corporation Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
JPH06509235A (en) * 1991-07-26 1994-10-20 ヴァイロジェネティクス　コーポレイション Infectious Bursal Disease Virus Recombinant Poxvirus Vaccine
US6231868B1 (en) * 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
WO2002088339A3 (en) 2004-01-22
WO2002088339A2 (en) 2002-11-07
FR2824327B1 (en) 2003-07-11
FR2824327A1 (en) 2002-11-08

Similar Documents

Publication Publication Date Title
AU2002367748A1 (en) Infectious disease microarray
AU2002236159A1 (en) Immunogenic complex
AU2002353378A1 (en) Vaccine for periodontal disease
AU2002359163A1 (en) New use
AUPQ912000A0 (en) Improved virus like particles
AU2002254558A1 (en) Novel vaccine
AU2002322059A1 (en) Improved vaccination against anthrax
AU2002349543A1 (en) Tumor antigens
AU2001283862A1 (en) Bvdv virus-like particles
AU2002310654A1 (en) Bursal disease virus-like particles
GB0201382D0 (en) Virus-like particles
AU2002367108A1 (en) Dna vaccine for periodontal disease
AU2003227026A1 (en) An infectious bursal disease virus variant
AU2002367423A1 (en) Hard capsules
AU2002346252A1 (en) Particle probe
AU2002236065A1 (en) Papillomavirus vaccines
AU2003237701A1 (en) Vaccines
AU2002347346A1 (en) Dna vaccine
AU2002314274A1 (en) Vaccination against the feline immunodeficiency virus
AU2002303093A1 (en) Mycobacterial vaccines
AU2003237906A1 (en) Virus-like particles
AU2002302785A1 (en) Vaccines
AUPR440001A0 (en) Vaccine
AU2002337263A1 (en) Anti-coronavirus vaccine
AU2002319485A1 (en) Dna vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase